UTAH MEDICAL PRODUCTS INC (UTMD) › Operating Cash FlowUTAH MEDICAL PRODUCTS INC (UTMD) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2009: $7.23M2010: $7.16M2011: $11.37M2012: $13.56M2013: $12.31M2014: $15.39M2015: $13.80M2016: $14.53M2017: $16.91M2018: $16.83M2019: $17.06M2020: $20.14M2021: $21.20M2022: $21.15M2023: $22.28M2024: $14.83M2025: $14.69M$14.69M2009Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$14.69M-0.9%2024$14.83M-33.4%2023$22.28M+5.4%2022$21.15M-0.3%2021$21.20M+5.3%2020$20.14M+18.1%2019$17.06M+1.3%2018$16.83M-0.4%2017$16.91M+16.4%2016$14.53M+5.3%2015$13.80M-10.3%2014$15.39M+25.0%2013$12.31M-9.3%2012$13.56M+19.3%2011$11.37M+58.8%2010$7.16M-1.0%2009$7.23M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share